SASerina S. Applebaum

Serina S. Applebaum

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Serina S. Applebaum has a total of 51 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Evaluation of Anal Cancer Screening Among 18-to-34-Year-Old Men Who Have Sex With Men Living With HIV Over a 10-Year Period

    by Serina S Applebaum, Elizabeth Chan, Michael Virata, Ritche Hao, Lydia Barakat, Amit C Achhra

    Guidelines now support anal squamous cell carcinoma (ASCC) screening in men who have sex with men (MSM) living with HIV (LWH) aged ≥35 years. There is limited data on screening in MSM LWH <35 years. Two academic HIV clinics in the Northeastern US. We retrospectively evaluated all anal cytology and high-resolution anoscopy (HRA; referral criteria: atypical cells of undetermined significance [ASC-US] or worse cytology) performed for MSM LWH between ages 18–34 from 2013 to 2023. We evaluated risk factors for abnormal cytology or histology, and prevalence of high-grade dysplasia (HSIL) and ASCC. Of 216 eligible MSM LWH, 111 (51%) were screened for ASCC at least once. Screened individuals had longer follow-up (median 4.0 vs 1.6 years) but were otherwise similar to unscreened individuals. Among 246 cytology tests, 19% were unsatisfactory and 31% abnormal, of which 1.2% reported HSIL. Of 23 HRAs following abnormal cytology, 10 (43%) revealed HSIL. Testing in response to symptoms was associated with abnormal results (OR 8.54; 95% CI 2.55–28.67). Human papillomavirus vaccination trended toward protection against abnormal results. We identified two cases of local ASCC, both in individuals with symptomatic condyloma and severe immunosuppression. Over 10 years, ASCC screening in MSM LWH <35 years was variable. Anal cytology had high unsatisfactory rates and poor correlation with histology. Despite high dysplasia prevalence among those undergoing HRA, ASCC was rare and diagnosed early from symptoms. Findings support excluding younger (≤34 years) MSM LWH from asymptomatic screening, and support symptom-driven testing to diagnose anal cancer early.

  • Open Access

    Diabetic retinopathy treatment cascade and care continuum in the USA: a systematic review

    by Julia Jieyu Fu, Serina S Applebaum, Alvaro Granados, Kristen Nwanyanwu

    Objectives: To characterise engagement across the diabetic retinopathy (DR) care continuum in the USA using a cascade-of-care framework and identify gaps contributing to preventable vision loss. Design: Systematic review. Data sources: From September to November 2025, with an updated search in March to April 2026 using the same eligibility criteria, we systematically searched Ovid MEDLINE and Ovid Embase supplemented by reviewing reference lists of relevant articles and opportunistic searches of the Centers for Disease Control and Prevention publications. Eligibility criteria: We included English - language US-based cross-sectional, cohort and case–control studies and systematic reviews containing US-based data published between 1 January 2018 and 31 December 2025 relevant to one of the defined DR cascade stages: (1) diagnosis of diabetes, (2) adherence to DR screening, (3) diagnosis of DR, (4) adherence to DR care and (5) DR-related blindness. We included systematic reviews only to inform DR-related blindness, where primary data were limited and excluded them from other stages to avoid double-counting. Exclusion criteria included studies not relevant to one of the defined DR cascade stages and editorial, perspective or commentary pieces. Data extraction and synthesis: Two reviewers independently screened studies, extracted data and assessed risk-of-bias using the Newcastle-Ottawa Scale and Risk of Bias in Systematic Reviews tool. We synthesised data narratively and organised via the DR treatment cascade framework. Results: Of 14 893 studies screened, 46 met the inclusion criteria. Cascade analysis revealed substantial losses in patient engagement at three stages: (1) only 15.5%–78.7% (median 59.4%, IQR 33.9%–74.0%) of individuals with diabetes obtain biennial DR screening; (2) a substantial 54.9%–88.5% (median 70.1%, IQR 62.5%–79.3%) of individuals with DR are unaware of their diagnosis; (3) only 30.9%–62.7% (median 52.0%, IQR 40.9%–59.1%) of individuals diagnosed with DR are initially linked to care and 55.3%–77.8% (median 70.3%, IQR 59.2%–77.7%) have a lapse in DR follow-up. Conclusions: This review identifies major gaps in the DR care continuum, particularly in diagnosis awareness, linkage to care and follow-up adherence. The cascade framework highlights key points of disengagement and provides a basis for prioritising future research.


  • Open Access

    Short-Term Preliminary Results of Outcomes with and without Tenonectomy During Open Conjunctival XEN45 Gel Stent Implantation

    by Serina S Applebaum, Addiskidan Hundito, Ismail Ajjawi, Christopher C Teng, Soshian Sarrafpour, Ji Liu

    Purpose: To compare outcomes of eyes with and without tenonectomy during ab externo open conjunctival (AEO) implantation of a gelatin stent (XEN45 Gel Stent [XGS]) with mitomycin C. Methods: We conducted a retrospective comparative cohort study of adults aged ≥ 40 with open-angle glaucoma and preoperative intraocular pressure (IOP) > 17mmHg who underwent XGS AEO with or without tenonectomy at a single academic center (April 2021-September 2023). We matched eyes undergoing tenonectomy 1:3 to controls using nearest-neighbor algorithm. The primary outcome was success at 1 year (6 ≤ IOP ≤ 21mmHg, with ≥ 20% reduction from baseline, with or without IOP-lowering medication). Secondary outcomes included IOP, medication burden, visual acuity, and postoperative complications and interventions. Results: We included 40 eyes (38 patients): 10 with tenonectomy and 30 without. At 1 year, 70%, 60%, and 40% of tenonectomy eyes and 55%, 52%, and 36% of non-tenonectomy eyes achieved success at IOP thresholds of 21, 18, and 15 mmHg, respectively (all p> 0.05). There were no significant differences between groups in IOP, medication burden, or visual acuity. At 1 year, mean IOP was 14.83 ± 2.08 on 1.13 ± 0.38 IOP-lowering medications in the tenonectomy group and 16.88 ± 1.53 on 1.36 ± 0.31 medications in the non-tenonectomy group. Tenonectomy eyes tended toward more early complications (30% vs 23%, p=0.69), but fewer postoperative interventions (30% vs 57%, p=0.28) and reoperations (20% vs 30%, p=0.70). Conclusion: Both techniques provided effective IOP control and reduced medication burden. In this short-term preliminary study, tenonectomy may be more effective than the traditional technique. Given the small sample size and retrospective design, findings should be interpreted cautiously. More data are needed to guide optimal surgical technique.

  • Open Access

    Who Gets Panretinal Photocoagulation? National Patterns in Proliferative Diabetic Retinopathy Treatment

    by Serina S. Applebaum, Julia Fu, Mathieu Bakhoum, Yanhong Deng, Kristen H. Nwanyanwu, Sejal Amin

  • Open Access

    Digital Health Tool for Preventing Blindness From Diabetic Retinopathy: Protocol for a Qualitative Study

    by Akua Frimpong, Alvaro Granados, Thomas Chang, Julia Fu, Serina S Applebaum, Shannan G Moore, Mahima Kaur, Bolatito Adepoju, Vignesh Hari Krishnan, Amanda Levi, et al.

    Background: Diabetic retinopathy (DR), a leading cause of preventable blindness among working-age adults, leads to worse health outcomes among Black, Latine, and individuals with lower income in comparison to other ethnic, racial, and socioeconomic groups in the United States. Objective: We aim to engage community members directly to identify barriers and facilitators of DR screening and co-design a digital health tool that is accessible, user-friendly, and community-responsive. Methods: We conducted focus groups with individuals from the Greater New Haven, Connecticut area, aged 18 years or older, and diagnosed with diabetes to (1) conduct a comprehensive disease-management needs assessment and (2) inform the development of a community-responsive digital health tool to optimize DR education and to increase access to DR screening in high-risk populations. We transcribed the focus group interviews, used rapid qualitative analysis to generate themes, and completed affinity mapping to identify content and features for a digital health tool for preventing blindness from DR. Results: We recruited and interviewed 19 individuals (13/19, 68% female; 9/19, 47% Black; 5/19, 26% Hispanic; 2/19, 11% Native American or Alaska Native) for 4 focus groups. Over 94% (18/19) had access to smart devices other than a computer. Participants self-reported mean hemoglobin A1c of 6.77 (SD 1.93). Approximately 58% (11/19) of the participants completed some college. Frequently occurring themes (>30) obtained from coding contextual interviews were desired app attributes such as options for customization, covering topics such as, the mental impact of living with diabetes, informal support (eg, peer support), diabetes education, barriers to controlling blood sugar and maintenance of health, dietary guidance, and notifications. We created high-fidelity wireframes incorporating key features. Next, we will iteratively design a prototype with community feedback. Conclusions: We anticipate that this study will characterize the experiences of people living with diabetes. Using a community-led approach,we will continue to analyze the data that will generate insights regarding the key features, content, and benefits that are most important for the creation of a digital health tool for DR prevention. International Registered Report Identifier (IRRID): DERR1-10.2196/65894

  • Risk Factors and Consequences of Lapses in Proliferative Diabetic Retinopathy Care in a National Cohort

    by Serina S Applebaum, Yanhong Deng, Julia J Fu, Michael Kane, Kristen H Nwanyanwu, Sight Outcomes Research Collaborative (SOURCE) Consortium

    OBJECTIVE: To identify prevalence, risk factors, and visual outcomes associated with occurrence and duration of lapses in proliferative diabetic retinopathy (PDR) care. RESEARCH DESIGN AND METHODS: This was a retrospective national cohort study (2008–2023) of adults with PDR and ≥6 months of follow-up who were participating in the Sight Outcomes Research Collaborative. We used multivariable regressions to assess factors associated with lapse occurrence and duration, and compared post-lapse visual acuity by lapse duration. RESULTS: Among 15,211 individuals, 71.8% experienced a lapse in care; 14.2% of the lapses lasted >24 months. Lapses were more common among non-Hispanic Black, younger, and individuals with disability, and less common in those with poor vision or prior PDR treatment. Older age and PDR treatment predicted shorter lapses, and residence in distressed areas predicted longer lapses. Visual acuity worsened after lapses, with greater declines after longer lapses. CONCLUSIONS: Prolonged lapses in PDR care are common, disproportionately affect vulnerable groups, and are associated with persistent vision loss.


  • Open Access

    Recommendations for Designing a Digital Health Tool for Blindness Prevention Among High-Risk Diabetic Retinopathy Patients: Qualitative Focus Group Study of Adults With Diabetes

    by Akua Frimpong, Alvaro Granados, Thomas Chang, Julia Fu, Shannan G Moore, Serina Applebaum, Bolatito Adepoju, Mahima Kaur, Vignesh Hari Krishnan, Amanda Levi, et al.

    Background: Diabetic retinopathy (DR) is a leading cause of preventable blindness among working-aged adults. Black, Latine, and low-income individuals are screened less for DR, diagnosed later, treated less often, and go blind more than White individuals. Objective: This study aimed to engage members to co-design a digital health tool that is accessible, user-friendly, and culturally relevant, through a community-led research approach,. Methods: Using a qualitative approach, we conducted 4 semistructured focus group interviews with 19 individuals from the Greater New Haven area, aged 18 years or older, and diagnosed with diabetes. We transcribed and coded the focus group interviews and categorized them into themes using affinity mapping. The specific aims were to complete a comprehensive needs assessmen for the development of a community-responsive digital health tool and to increase access to information about DR screening in high-risk populations. We transcribed the focus group interviews, used rapid qualitative analysis to generate themes, and completed affinity mapping to identify content and features for a digital health tool for preventing blindness from DR. Results: We interviewed 19 individuals (68% [13/19] female, 47% [9/19] Black, 26% [5/19]) Hispanic) in 4 focus groups. Over 80% (15/19) had access to smart devices, including smartphones (17/19, 89%), smartwatches (4/19, 21%), computers (14/19, 74%), and tablets (11/19, 58%). Many participants had access to multiple devices (17/19, 89%). Participants self-reported hemoglobin A1c (mean hemoglobin A1c 6.77, SD 1.93) and age (mean age 58.79, SD 19.54). Education levels among participants varied. Almost half of all the participants (9/19, 47%) completed some college, a little less than a quarter (4/19, 21%) achieved a high school diploma or general education development certificate, and a little less than a quarter (4/19, 21%) completed less than a high school equivalent of education. Household income levels across nearly all participants (14/19, 74%) were below US $50,000, but household size data were not collected. Participants reported extensive experience with diabetes or prediabetes (mean years with diabetes or prediabetes 17.06, SD 17.53). The themes obtained from coding focus group interviews included the mental toll of diabetes, peer support like accountability and local community events, education about diabetes management, barriers to DR screening like long wait times for appointments or cost of medications, and diet-related topics like how to find cost-effective healthy food Conclusions: DR is one of the leading causes of blindness, and many treatments exist. Despite the existence of treatments, historically marginalized populations experience poor health outcomes, including blindness. Our community-based approach aids in the creation of a culturally responsive digital health tool.


  • Open Access

    Five-Year Evaluation of an Anal Cancer Screening Program in Men Who Have Sex With Men With HIV at 2 Academic Center Clinics

    by Amit C Achhra, Elizabeth Chan, Serina Applebaum, Maggie Guerrero, Ritche Hao, Haddon Pantel, Michael Virata, Margaret Fikrig, Lydia Barakat

    Background: Guidelines recommend annual anal cytology-based squamous cell carcinoma of anus (SCCA) screening for men who have sex with men with HIV aged ≥35 years (eligible population). The recommended threshold for high-resolution anoscopy (HRA) depends on its availability: low-threshold (any abnormal cytology) if availability is high and high-threshold (high-grade squamous intraepithelial lesion [HSIL] on cytology) if availability is low. Methods: This was a retrospective chart review (2018–2022) at academic HIV clinics. We evaluated (1) 5-year uptake of cytology-based SCCA screening in the eligible population and (2) estimated HSIL detection rate based on our current low-threshold criteria, and if high-threshold criteria were used for HRA referral. Results: Of 432 eligible individuals, only 219 (50.7%) had at least 1 and only 113 (26%) had >1 SCCA screening tests in a median follow-up of 4 years. Seventy-four (17.1%) individuals had at least 1 abnormal anal cytology during follow-up, of whom 56 (75.6%) underwent HRA. Increasing age (≥57 years) and history of smoking negatively correlated with ever receiving screening. Anal cytology (365 tests in 206 individuals) showed 17.5% “unsatisfactory” and 26.8% with any abnormal cytology (zero with HSIL) triggering HRA referral. Only 34 individuals (7.8% of screening eligible) were ever detected with HSIL. Strictly using high-threshold criteria for HRA referral would have led to no HRA or HSIL detection. Conclusions: We noted poor uptake of screening over time, particularly in older age groups. Importantly, anal cytology performed poorly as a triage test for HRA referral, with high rates of “unsatisfactory” samples and low sensitivity for detecting HSIL.


  • Open Access

    Digital Health Tool for Preventing Blindness From Diabetic Retinopathy: Protocol for a Qualitative Study (Preprint)

    by Akua Frimpong, Alvaro Granados, Thomas Chang, Julia Fu, Serina S Applebaum, Shannan G Moore, Mahima Kaur, Bolatito Adepoju, Vignesh Hari Krishnan, Amanda Levi, et al.

    BACKGROUND Diabetic retinopathy (DR), a leading cause of preventable blindness among working-age adults, leads to worse health outcomes among Black, Latine, and individuals with lower income in comparison to other ethnic, racial, and socioeconomic groups in the United States. OBJECTIVE We aim to engage community members directly to identify barriers and facilitators of DR screening and co-design a digital health tool that is accessible, user-friendly, and community-responsive. METHODS We conducted focus groups with individuals from the Greater New Haven, Connecticut area, aged 18 years or older, and diagnosed with diabetes to (1) conduct a comprehensive disease-management needs assessment and (2) inform the development of a community-responsive digital health tool to optimize DR education and to increase access to DR screening in high-risk populations. We transcribed the focus group interviews, used rapid qualitative analysis to generate themes, and completed affinity mapping to identify content and features for a digital health tool for preventing blindness from DR. RESULTS We recruited and interviewed 19 individuals (13/19, 68% female; 9/19, 47% Black; 5/19, 26% Hispanic; 2/19, 11% Native American or Alaska Native) for 4 focus groups. Over 94% (18/19) had access to smart devices other than a computer. Participants self-reported mean hemoglobin A1c of 6.77 (SD 1.93). Approximately 58% (11/19) of the participants completed some college. Frequently occurring themes (>30) obtained from coding contextual interviews were desired app attributes such as options for customization, covering topics such as, the mental impact of living with diabetes, informal support (eg, peer support), diabetes education, barriers to controlling blood sugar and maintenance of health, dietary guidance, and notifications. We created high-fidelity wireframes incorporating key features. Next, we will iteratively design a prototype with community feedback. CONCLUSIONS We anticipate that this study will characterize the experiences of people living with diabetes. Using a community-led approach,we will continue to analyze the data that will generate insights regarding the key features, content, and benefits that are most important for the creation of a digital health tool for DR prevention. INTERNATIONAL REGISTERED REPORT DERR1-10.2196/65894

  • Open Access

    Health Tool for Blindness Prevention among High-Risk Diabetic Retinopathy Patients: A Focus Group Study With Adults With Diabetes (Preprint)

    by Akua Frimpong, Alvaro Granados, Thomas Chang, Julia Fu, Shannan G Moore, Serina Applebaum, Bolatito Adepoju, Mahima Kaur, Vignesh Hari Krishnan, Amanda Levi, et al.

    BACKGROUND Diabetic retinopathy (DR), a leading cause of preventable blindness among working-aged adults. Black, Latine, and individuals living in poverty are screened less for DR, diagnosed later, treated less often, and go blind more than wealthy white individuals. OBJECTIVE Through a community-led research approach, this project engaged community members directly to co-design a digital health tool that is accessible, user-friendly, and culturally relevant. METHODS Using a qualitative approach, we conducted 4 semi-structured focus groups with 19 individuals from the Greater New Haven area, aged 18 years or older, and diagnosed with diabetes. We transcribed and coded contextual interviews and categorized them into themes using affinity mapping. The study has two specific aims: (1) to complete a comprehensive needs assessment aimed at (2) developing a community-responsive digital health tool to increase access to and knowledge of diabetic retinopathy (DR) screening in high-risk populations. We transcribed the focus group interviews, used rapid qualitative analysis to generate themes, and completed affinity mapping to identify content and features for a digital health tool for preventing blindness from diabetic retinopathy. RESULTS We interviewed 19 individuals (68% female, 47% Black, 26% Hispanic,11% indigenous) in 4 focus groups. Over 80% had access to smart devices. Participants’ self-reported mean [SD] A1c was 6.77 [1.93]. Age mean [SD] was 58.79 [19.54]. Almost half (48%) of participants completed some college. The principal themes obtained from coding contextual interviews were desired app attributes, mental impact, informal support, content knowledge related to diabetes, barriers, diet-related topics, and receiving notifications. CONCLUSIONS DR is one of the leading causes of blindness, and many treatments exist. Despite the existence of treatments, historically marginalized populations experience poor health outcomes, including blindness. Our community-based approach empowers the creation of a culturally sensitive digital health tool that will engage more of the patient population with DR.